Asian Spectator

Times Advertising

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Ancaman blokir Wikipedia: Tanda kuatnya hasrat negara mengontrol narasi publik

shutterstock(Pixinoo/Shutterstock)● Ancaman blokir Wikipedia menandai obsesi negara memperluas kontrol atas infrastruktur pengetahuan publik.● Regulasi menjadi instrumen yang memaksa platf...

Bukan cuma ikan sapu-sapu, ada banyak spesies invasif di perairan kita termasuk ikan nila

● Spesies invasif seperti ikan sapu-sapu, red devil, ikan cere, dan nila merupakan ancaman serius bagi ikan-ikan lokal.● Penyebaran spesies invansif terjadi akibat aktivitas manusia (perda...

Toleransi di ruang digital: Bagaimana tayangan Youtube ‘Login’ menggeser metode dakwah konvensional

● Media sosial mengubah ekspresi toleransi yang kaku, elitis, dan ‘top-down’ menjadi lebih cair dan egaliter.● Program seperti ‘Login’ membumikan isu agama yang ber...